Finland· FI-REL-REL43754
Hepatect
A hepatitis b immunoglobulin product containing human plasma protein + human hepatitis b immunoglobulin, registered in Finland by Biotest Pharma GmbH. The same ATC class is registered in 12 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Hepatitis b immunoglobulin is registered in 12 of 19 countries.
Countries holding a registration under ATC J06BB04 (hepatitis b immunoglobulin), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Hepatitis b immunoglobulin · ATC J06BB04
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Fimea (Finland)- Active substance
- Human plasma protein + Human hepatitis B immunoglobulin
- Manufacturer
- Biotest Pharma GmbH
- Country
- Finland (FI)
- ATC code
- J06BB04
- ATC class
- Hepatitis B immunoglobulin
- Defined daily dose
- 500 E, P
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J06BB04
Hepatitis b immunoglobulin, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/07c62076-fe2e-4637-a5c7-1a1f3ef1bc26 GET /v1/drugs/07c62076-fe2e-4637-a5c7-1a1f3ef1bc26?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "infuusioneste, liuos",
"route": "Laskimoon",
"ddd_unit": null,
"strength": "50 IU/ml",
"atc_label": "hepatiitti-B-immunoglobuliini",
"ma_number": "31579",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL43754",
"authorised_at": "2014-08-25"
}See everything about hepatitis b immunoglobulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.